Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,087 | -27,316 | -36,052 | -24,436 | -55,287 |
| Depreciation Amortization | 4,204 | 3,038 | 2,003 | 1,011 | 4,090 |
| Income taxes - deferred | -3,823 | N/A | N/A | N/A | N/A |
| Accounts receivable | -12,348 | -11,053 | -8,861 | -6,198 | -17,871 |
| Accounts payable and accrued liabilities | 7,272 | 1,388 | 2,164 | -2,320 | 2,625 |
| Other Working Capital | 48,952 | 53,377 | 35,364 | 8,140 | 5,782 |
| Other Operating Activity | 32,891 | 20,578 | 24,267 | 19,216 | 63,601 |
| Operating Cash Flow | $26,061 | $40,012 | $18,885 | $-4,587 | $2,940 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -350,000 | -350,000 | -350,000 | N/A | N/A |
| PPE Investments | -5,129 | -1,589 | -761 | -430 | -5,425 |
| Investing Cash Flow | $-355,129 | $-351,589 | $-350,761 | $-430 | $-5,425 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 402,500 | 402,500 | 402,500 | N/A |
| Debt Repayment | -50,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 6,800 | 6,250 | 6,052 | 5,754 | 34,346 |
| Other Financing Activity | 387,081 | -13,358 | -13,358 | -12,242 | 0 |
| Financing Cash Flow | $343,881 | $395,392 | $395,194 | $396,012 | $34,346 |
| Exchange Rate Effect | -1,708 | 11,326 | -959 | -800 | 8,293 |
| Beginning Cash Position | 442,626 | 442,626 | 442,626 | 442,626 | 402,472 |
| End Cash Position | 455,731 | 537,767 | 504,985 | 832,821 | 442,626 |
| Net Cash Flow | $13,105 | $95,141 | $62,359 | $390,195 | $40,154 |
| Free Cash Flow | |||||
| Operating Cash Flow | 26,061 | 40,012 | 18,885 | -4,587 | 2,940 |
| Capital Expenditure | -5,173 | -1,589 | -761 | -430 | -5,425 |
| Free Cash Flow | 20,888 | 38,423 | 18,124 | -5,017 | -2,485 |